PCR70 Avalglucosidase Alfa (AVA) Improves Symptoms and Functioning in Late-Onset Pompe Disease (LOPD) Patients vs Alglucosidase Alfa (ALG): Post-Hoc Analyses of Patient-Reported Outcomes (PROs) From COMET Trial
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.2005
https://www.valueinhealthjournal.com/article/S1098-3015(22)04210-3/fulltext
Title :
PCR70 Avalglucosidase Alfa (AVA) Improves Symptoms and Functioning in Late-Onset Pompe Disease (LOPD) Patients vs Alglucosidase Alfa (ALG): Post-Hoc Analyses of Patient-Reported Outcomes (PROs) From COMET Trial
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)04210-3&doi=10.1016/j.jval.2022.09.2005
First page :
Section Title :
Open access? :
No
Section Order :
11558